Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Jan;35(1):62–67. doi: 10.1128/aac.35.1.62

Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.

M S Smith 1, R J Thresher 1, J S Pagano 1
PMCID: PMC244942  PMID: 1707604

Abstract

Some murine retroviruses exhibit altered release of virus when cells are treated with alpha interferon (IFN-alpha), resulting in the accumulation of intracellular virions in cytoplasmic vacuoles. In studies of the inhibitory effect of IFN-alpha (Wellferon) on acute human immunodeficiency virus type 1 infection of human T-cell lines, we found that in C3 cells, the 50% effective concentration was 9 U/ml and the 90% effective concentration was 310 U/ml. There was no apparent accumulation of intracellular particles detected by p24 antigen levels or by processing the cells for electron microscopy. Extracellular reverse transcriptase activity and p24 levels decreased in parallel with increasing IFN, whereas the intracellular viral proteins decreased only slightly. By electron microscopy, cells treated with higher concentrations of IFN (512 U/ml) disclosed very few particles budding into extracellular spaces; no intracellular particles could be seen, despite nearly normal levels of intracellular viral protein detected by the p24 antigen assay and correct processing detected by Western blot (immunoblot) analysis. Thus in human immunodeficiency virus-infected cells, the major block produced by IFN-alpha appeared to be late in the viral cycle at the morphogenesis stage of virion production. Chronically infected Jurkat cells treated with IFN appeared to be inhibited in growth rate, as virus production decreased proportionally with cell number.

Full text

PDF
62

Images in this article

64Image
on p.64
65Image
on p.65

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aboud M., Kimchi R., Bakhanashvili M., Salzberg S. Intracellular production of virus particles and viral components in NIH/3T3 cells chronically infected with Moloney murine leukemia virus: effect of interferon. J Virol. 1981 Dec;40(3):830–838. doi: 10.1128/jvi.40.3.830-838.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Avery R. J., Norton J. D., Jones J. S., Burke D. C., Morris A. G. Interferon inhibits transformation by murine sarcoma viruses before integration of provirus. Nature. 1980 Nov 6;288(5786):93–95. doi: 10.1038/288093a0. [DOI] [PubMed] [Google Scholar]
  3. Bilello J. A., Wivel N. A., Pitha P. M. Effect of interferon on the replication of mink cell focus-inducing virus in murine cells: synthesis, processing, assembly, and release of viral proteins. J Virol. 1982 Jul;43(1):213–222. doi: 10.1128/jvi.43.1.213-222.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chou T. C., Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55. doi: 10.1016/0065-2571(84)90007-4. [DOI] [PubMed] [Google Scholar]
  5. Friedman R. M. Antiviral activity of interferons. Bacteriol Rev. 1977 Sep;41(3):543–567. doi: 10.1128/br.41.3.543-567.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hartshorn K. L., Neumeyer D., Vogt M. W., Schooley R. T., Hirsch M. S. Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro. AIDS Res Hum Retroviruses. 1987 Summer;3(2):125–133. doi: 10.1089/aid.1987.3.125. [DOI] [PubMed] [Google Scholar]
  7. Hartshorn K. L., Vogt M. W., Chou T. C., Blumberg R. S., Byington R., Schooley R. T., Hirsch M. S. Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon. Antimicrob Agents Chemother. 1987 Feb;31(2):168–172. doi: 10.1128/aac.31.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ho D. D., Hartshorn K. L., Rota T. R., Andrews C. A., Kaplan J. C., Schooley R. T., Hirsch M. S. Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro. Lancet. 1985 Mar 16;1(8429):602–604. doi: 10.1016/s0140-6736(85)92144-0. [DOI] [PubMed] [Google Scholar]
  9. Leary J. J., Brigati D. J., Ward D. C. Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bio-blots. Proc Natl Acad Sci U S A. 1983 Jul;80(13):4045–4049. doi: 10.1073/pnas.80.13.4045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Morris A. G., Burke D. C. An interferon-sensitive early step in the establishment of infection of murine cells by murine sarcoma/leukaemia virus. J Gen Virol. 1979 Apr;43(1):173–181. doi: 10.1099/0022-1317-43-1-173. [DOI] [PubMed] [Google Scholar]
  11. Munn R. J., Marx P. A., Yamamoto J. K., Gardner M. B. Ultrastructural comparison of the retroviruses associated with human and simian acquired immunodeficiency syndromes. Lab Invest. 1985 Aug;53(2):194–199. [PubMed] [Google Scholar]
  12. Naso R. B., Wu Y. H., Edbauer C. A. Antiretroviral effect of interferon: proposed mechanism. J Interferon Res. 1982;2(1):75–96. doi: 10.1089/jir.1982.2.75. [DOI] [PubMed] [Google Scholar]
  13. Pitha P. M., Wivel N. A., Fernie B. F., Harper H. P. Effect of interferon on murine leukaemia virus infection. IV. Formation of non-infectious virus in chronically infected cells. J Gen Virol. 1979 Mar;42(3):467–480. doi: 10.1099/0022-1317-42-3-467. [DOI] [PubMed] [Google Scholar]
  14. Poli G., Orenstein J. M., Kinter A., Folks T. M., Fauci A. S. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science. 1989 May 5;244(4904):575–577. doi: 10.1126/science.2470148. [DOI] [PubMed] [Google Scholar]
  15. Sen G. C. Biochemical pathways in interferon-action. Pharmacol Ther. 1984;24(2):235–257. doi: 10.1016/0163-7258(84)90036-6. [DOI] [PubMed] [Google Scholar]
  16. Smith M. S., Brian E. L., De Clercq E., Pagano J. S. Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine. Antimicrob Agents Chemother. 1989 Sep;33(9):1482–1486. doi: 10.1128/aac.33.9.1482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Smith M. S., Brian E. L., Pagano J. S. Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine. J Virol. 1987 Dec;61(12):3769–3773. doi: 10.1128/jvi.61.12.3769-3773.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Strube W., Strube M., Kroath H., Jungwirth C., Bodo G., Graf T. Interferon inhibits establishment of fibroblast infection with avian retroviruses. J Interferon Res. 1982;2(1):37–49. doi: 10.1089/jir.1982.2.37. [DOI] [PubMed] [Google Scholar]
  19. Terwilliger E. F., Cohen E. A., Lu Y. C., Sodroski J. G., Haseltine W. A. Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5163–5167. doi: 10.1073/pnas.86.13.5163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Vogt M. W., Durno A. G., Chou T. C., Coleman L. A., Paradis T. J., Schooley R. T., Kaplan J. C., Hirsch M. S. Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1. J Infect Dis. 1988 Aug;158(2):378–385. doi: 10.1093/infdis/158.2.378. [DOI] [PubMed] [Google Scholar]
  22. Wong P. K., Yuen P. H., MacLeod R., Chang E. H., Myers M. W., Friedman R. M. The effect of interferon on de novo infection of Moloney murine leukemia virus. Cell. 1977 Feb;10(2):245–252. doi: 10.1016/0092-8674(77)90218-5. [DOI] [PubMed] [Google Scholar]
  23. Yamamoto J. K., Barré-Sinoussi F., Bolton V., Pedersen N. C., Gardner M. B. Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. J Interferon Res. 1986 Apr;6(2):143–152. doi: 10.1089/jir.1986.6.143. [DOI] [PubMed] [Google Scholar]
  24. Zens W., Degen H. J., Barnekow A., Gelderblom H., Jungwirth C. Two interferon sensitive steps in the replication cycle of Rous sarcoma virus. Virology. 1989 Aug;171(2):535–542. doi: 10.1016/0042-6822(89)90623-5. [DOI] [PubMed] [Google Scholar]
  25. Ziegler R. E., Joklik W. K. Effect of interferon on multiplication of avian sarcoma virus B77 in duck embryo fibroblasts. J Interferon Res. 1981;1(4):521–538. doi: 10.1089/jir.1981.1.521. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES